Welcome to the Working Group on New TB Drugs Blog
Posted in Announcements, Early Drug Development, Events, Front Lines of TB R&D, TB Drug Development
TB R&D Weekly Update: Marine Drug Discovery Symposium at the NYAS
This week in TB R&D, we are highlighting a symposium hosted by The New York Academy of Sciences entitled “New Frontiers in Marine Drug Discovery” on May 20, 2011. This 1-day symposium will overview the current state of the art in Marine Biomedicine and its role in the context of the drug discovery process. Additional TB R&D news links are included.
Posted in Announcements, Early Drug Development, Front Lines of TB R&D, TB Drug Development, TB News, TB Treatment
First Chinese Product Development Partnership for TB, Malaria and HIV/AIDS Announced
Today on World TB Day, the International Scientific Exchange Foundation of China (ISEFC), announced the signing of a Memorandum of Understanding with the Global Alliance for TB Drug Development (TB Alliance) to establish the Global Health R&D Center of China (GHRC). This innovative center will focus on the development of treatments for the world’s leading infectious disease killers—tuberculosis, malaria, and HIV/AIDS.
BIO Ventures for Global Health Launches New Online Tool
This week BIO Ventures for Global Health launched a new online tool called the “Global Health Primer” which aims to be a clearinghouse of information geared to the biotech industry to encourage investments in neglected disease product development.
TB R&D Weekly Update: Redefining Tuberculosis Immunopathology
In this week’s TB R&D update, we look at whether researchers should change their view and definitions of immunopathology in tuberculosis. The authors suggest that the term “caseous necrosis” should actually be split into three processes. The article is published in the February issue of Science Translational Medicine and is entitled “Tuberculosis immunopathology: the neglected role of extracellular matrix destruction.” Also, links to additional news in TB R&D are included.
Posted in Early Drug Development, Front Lines of TB R&D, TB Drug Development, TB R&D Spotlight Interviews, WGND Podcast Series
TB R&D Weekly Update: Podcast Interview with Philip Bourne
In this week”s TB R&D update, The WGND had the opportunity to talk with Dr. Bourne on a recent article published in PLoS Computational Biology in November 2010. Dr. Philip Bourne is a professor at University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences and Editor in Chief of PL0S Computational Biology. In the interview, Dr. Bourne discusses his present research, use of structural bioinformatics to inform drug discovery, and the need for open access in research. Also, links to additional news in TB R&D are included.
Posted in Early Drug Development, Front Lines of TB R&D, TB News, TB Prevention and Control Strategies
TB R&D Weekly Update: TB Vaccine Demonstrates Protection Pre- and Post-exposure
In this week’s TB R&D update, we look at a novel vaccine that shows protection against TB before and after exposure. The research is published in the January issue of Nature Medicine and is entitled “A multistage tuberculosis vaccine that confers efficient protection before and after exposure”. Also, links to additional news in TB R&D are included.
Mycobacterium tuberculosis Evades Host Immunity by Recruiting Mesenchymal Stem Cells
On the early drug discovery front, this study may provide researchers additional areas to target for compounds against tuberculosis. Raghuvanshi, et al. conducted experiments in mice investigating the role of mesenchymal stem cells (MSCs) in infection with tuberculosis.
-
You are currently browsing the archives for the Early Drug Development category.
-
Toppix TB News- TB, a neglected disease in Uganda 15 May 2013
- Dr. John: Medications, T.B, tinnitus 8 May 2013
- U.S. non-profit group to build tuberculosis center in Pyongyang 4 May 2013
- Predictors of tuberculosis (TB) and antiretroviral (ARV) medication... 26 Apr 2013
- Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr.... 26 Apr 2013
